Skip to main content
1266 search results for:

Semaglutide 

sort by |
"newest" sorts results by publication date. "most relevant" also considers factors like how often the search phrase is in the result.
  1. 01-05-2024 | Semaglutide | News

    Semaglutide

    Acute appendicitis
  2. 01-05-2024 | Insulins | News

    Semaglutide

    Euglycaemic diabetic ketoacidosis
  3. 01-05-2024 | Semaglutide | News

    Semaglutide/Tacrolimus

    Various toxicities
  4. 01-04-2024 | Semaglutide | News

    Semaglutide

    Various toxicities
  5. 01-04-2024 | Semaglutide | News

    Semaglutide

    Gastrointestinal disturbances following intentional semaglutide misuse by dose increase
  6. 01-04-2024 | Semaglutide | News

    Semaglutide

    Progression of diabetic retinopathy
  7. 01-04-2024 | Semaglutide | News

    Compounded semaglutide product substandard

  8. Open Access 01-12-2024 | Semaglutide | OriginalPaper

    Cost-effectiveness of semaglutide 2.4 mg in chronic weight management in Portugal

    Obesity presents a significant clinical and public health concern, with prevention and management emerging as global priorities [ 1 ]. It is characterized by abnormal or excessive fat accumulation, which can impair health and increase the risk of …

  9. Open Access 09-05-2024 | Semaglutide | Online First

    Real-World Treatment Patterns Among Patients with Type 2 Diabetes Mellitus Initiating Treatment with Oral Semaglutide

    Diabetes mellitus affects one in ten Americans, with 90‒95% of patients with diabetes diagnosed with type 2 diabetes mellitus (T2DM) [ 1 ]. T2DM rarely occurs on its own and is typically associated with a host of comorbid conditions. Comorbidities …

  10. Open Access 09-05-2024 | Semaglutide | Online First

    Real-World Clinical Experience of Oral Semaglutide in a Secondary Diabetes Clinic in the UK: A Retrospective Observational Study

    Clinical interest in therapies for people with type 2 diabetes (T2D) has prospered in the last decade with many demonstrating a major impact beyond glycemic control. In clinical trials, at least, glucagon-like peptide-1 receptor analogues …

  11. 01-03-2024 | Semaglutide | News

    Semaglutide

    Semaglutide induced hyposalivation
  12. 01-03-2024 | Semaglutide | News

    Semaglutide

    Acute renal failure
  13. 22-04-2024 | Semaglutide | Online First

    Semaglutide attenuates pathological electrophysiological remodeling in diabetic cardiomyopathy via restoring Cx43 expression

    The prevalence of diabetes mellitus (DM) keeps increasing globally, with approximately 10% of the world’s population (537 million people) living with diabetes as estimated by the International Diabetes Federation in 2019, and it is predicted that …

  14. 16-04-2024 | Type 2 Diabetes | News | Article
    ACC 2024

    Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

    STEP-HFpEF trial findings indicate that weekly semaglutide improves heart failure symptoms, physical limitations, and body weight in people with obesity-related heart failure and type 2 diabetes.

  15. 13-05-2024 | Semaglutide | Online First

    Correction: Separate and combined effects of semaglutide and empagliflozin on kidney oxygenation and perfusion in people with type 2 diabetes: a randomised trial

  16. Open Access 29-04-2024 | Semaglutide | Online First

    Real-world use of oral versus subcutaneous semaglutide in a cohort of type 2 diabetic patients: which option to which patient?

    Glucagon-like peptide-1 receptor agonists (GLP1-RAs) are an effective class of drugs for the treatment of type 2 diabetes mellitus (T2D), with well-defined safety and tolerability profiles. Their use is associated with better glycemic control and …

  17. Open Access 30-04-2024 | Semaglutide | Online First

    Glycemic Control and Body Weight Reduction with Once-Weekly Semaglutide in Colombian Adults with Type 2 Diabetes: Findings from the COLIBRI Study

    In Colombia, approximately 3.5 million people live with diabetes, with the majority having Type 2 diabetes (T2D) [ 1 ]. Diabetes complications, specifically cardiovascular and renal disease, impose a significant burden on Colombia's healthcare …

  18. 29-12-2023 | Semaglutide | Letter

    Comment on: Semaglutide and cardiovascular outcomes in obesity without diabetes

  19. 02-03-2024 | Tirzepatide | OriginalPaper

    Semaglutide and Tirzepatide for the Management of Weight Recurrence After Sleeve Gastrectomy: A Retrospective Cohort Study

    Metabolic and bariatric surgery (MBS) is the most effective treatment for obesity and improvement of obesity-associated comorbidities [ 1 ]. However, a proportion of these patients may suffer from weight recurrence and recurrence of …

  20. Open Access 01-12-2024 | Semaglutide | OriginalPaper

    The long-term cost-effectiveness of once-weekly semaglutide versus sitagliptin for the treatment of type 2 diabetes in China

    There is a global epidemic of diabetes. China has the world’s largest number of diabetes population, with approximately 140.9 million people with a diagnosis, leading to associated deaths of 1.4 million and health expenditure of $165.3 billion in …

Filter search results

Search Operators:

„ ... ... “ Finds documents with exactly this word group, in exactly this word order and spelling (e.g., "employer branding").
AND Finds documents with both search terms (e.g., sales AND bonus).
OR Finds documents with one or the other search term (e.g., porsche OR volkswagen).
Blank Space Finds documents with all search terms. Blank space is understood as AND (e.g., man robot production).
NOT Finds documents with no appearance of the word behind NOT (e.g., ford NOT "harrison ford").
COUNT(...)>n Finds documents where the search term is mentioned at least "n" times."n" may be any number (e.g., COUNT(gear)>8).
NEAR(..., ..., ) Finds documents with both search terms in any word order, permitting "n" words as a maximum distance between them. Best choose between 15 and 30 (e.g., NEAR(recruit, professionals, 20)).
* Finds documents with the search term in word versions or composites. The star * marks whether you wish them BEFORE, BEHIND, or BEFORE and BEHIND the search term (e.g., lightweight*, *lightweight, *lightweight*).
? Finds documents with the search termn in different spellings."?" allows only one character (e.g., organi?ation).
& + - Special characters are understood as AND (e.g., Miller Bros. & Sons).

You can use operators in your search query to narrow down your results even more.

Tap the operator, or hover the mouse pointer over it, to read more about how it works.